Practice
Featured experience
Goldman Sachs $9.5 billion sale of Boyd Thermal and related business separations
We are advising Goldman Sachs Merchant Banking Division and its portfolio company Boyd on the transactions
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
Rent the Runway growth recapitalization
We advised Rent the Runway on the transactions
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Davis Polk Advises Penumbra, Inc. on Its $138 Million Initial Public Offering
Davis Polk advised Penumbra, Inc. on its SEC-registered initial public offering of 4,600,000 shares of common stock for an…
Davis Polk Advises Dialog Semiconductor on Its Acquisition of Atmel
Davis Polk is advising Dialog Semiconductor plc in connection with its $4.6 billion acquisition of Atmel Corporation…
Davis Polk Advises MSCI on Its Acquisition of Insignis
Davis Polk is advising MSCI Inc. in connection with its acquisition of all of the assets of Insignis, Inc. Financial terms…
Davis Polk Advises SS&C on Its Acquisition of Primatics Financial
Davis Polk is advising SS&C Technologies Holdings, Inc. in connection with its approximately $122 million acquisition of…
Davis Polk Advises Lar España Real Estate SOCIMI, S.A. on Its €135 Million Equity Offering
Davis Polk advised Lar España Real Estate SOCIMI, S.A. (Lar España) as to U.S. and English law in connection with its…
Davis Polk Advises Roper Technologies on Its Acquisition of RF IDeas
Davis Polk advised Roper Technologies, Inc. in connection with its acquisition of RF IDeas, Inc. The financial terms of the…
Davis Polk Advises RoundTable Healthcare Partners on the Formation of Its Equity Fund IV and Capital Fund III
Davis Polk advised RoundTable Healthcare Partners (“RoundTable”) in connection with the formation of, and the sale of…
Davis Polk Advises SS&C on Its Acquisition of Citigroup’s Alternative Investor Services Business
Davis Polk is advising SS&C Technologies Holdings, Inc. in connection with its acquisition of Citigroup’s Alternative…
Aimmune Therapeutics, Inc. $183.9 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $183.9 million initial public offering of Aimmune Technologies,…
Davis Polk Advises PartnerRe on Its Acquisition by EXOR
Davis Polk is advising PartnerRe Ltd. in connection with its approximately $6.9 billion acquisition by EXOR S.p.A. In…